Achievements of UZH Spin-offs

UZH Spin-offs are impressive both in their development and their success – the latest news is outlined below:

Delta Labs Team

07.04.2026 | The UZH Startup Delta Labs has raised EUR 4.4 million in a seed round led by Cusp Capital and Auxxo Female Catalyst Fund. The company develops AI-powered customer simulation tools that help businesses anticipate how customers will respond to decisions before they are made. With this round of funding, they are investing in the further development of Elaiia, their AI-powered customer simulation platform and in the continued expansion of their team.  
Delta Labs was founded in 2022 by Anne Scherer, a former University of Zurich professor and Cindy Candrian, who completed her PhD at UZH. The company was awarded the UZH Startup Label. 
Article startupticker.ch

23.03.2026 | In 2025, research conducted at UZH gave rise to 27 patent and trademark applications and 57 inventions. This is in line with the university’s excellent track record: over the past 10 years, a total of 722 inventions and 353 patent applications have emerged from UZH. They include innovations in oncology, diagnostics, artificial intelligence, imaging, agricultural science and veterinary medicine, among others.
In addition, four new spin-offs emerged as a result of research at UZH. They are working to find suitable treatments for individual patients, detect eye misalignments using smartphones, combat rare genetic diseases, and make the evaluation of neuropsychological examinations more efficient.
Full Article at UZH News
 

Valentina Vongrad, CSO FimmCyte

16.03.2026 | The UZH Spin-off has entered a strategic research collaboration with Gedeon Richter Plc. to develop a potential new treatment for endometriosis. The project focuses on FMC2, a therapy designed to target the underlying cause of the disease, which affects around one in ten women worldwide. FimmCyte will work with Gedeon Richter to advance the program through preclinical development toward first clinical studies. 
Co-founder and CSO Valentina Vongrad was awarded a UZH Entrepreneur Fellowship in 2022.
Full Article
News FimmCyte

Foto Wyss Zurich

15.01.2026 | Bio-engineered skin grafts can play an important role in the treatment of burn victims. Researchers at UZH have been working on new approaches for such grafts for over 15 years. This work led to the creation of Cutiss in 2017, a spin-off that produces living skin tissue from the patients’ own cells. 
UZH article "New Skin for Burn Victims"

Claudia Scheckel, CEO Oncobit

03.12.2025 | The UZH Spin-off has successfully secured CHF 1.9 million in a new financing round. The additional capital will support the company's clinical developments for next-generation cancer monitoring solutions and broaden its reach into new markets.
Entire news story
Oncobit announcement

CUTISS Team

22.09.2025 | The UZH Spin-off has successfully raised 56 CHF million in a Series C financing round. This investment will support the ongoing Phase 3 studies on denovoSkin™ and prepare for its market launch.
Entire news story
CUTISS announcement
 

08.09.2025 | Since 2011 the TOP 100 Swiss Startup Ranking has been selecting the most promising young companies in Switzerland. The 2025 ranking shows the UZH's outstanding role as a nurturing group for innovative life sciences startups. Special Congratulations to MUVON that makes it Top 3 in BioTech and to the Newcomers MetaLead and Nerai Biosciences!

Entire news story
TOP 100 Swiss Startup Ranking

Dario Dornbirer, Co-Founder

22.08.2025 | The UZH Spin-off has successfully emerged from stealth mode and is on track to bring its groundbreaking therapies for neuropsychiatric disorders to patients. Through novel, specifically developed pharmacological agents, they are developing therapies for neuropsychiatric disorders such as PTSD, anxiety disorders, insomnia, and addiction. 

Entire news story

askEarth Team

25.07.2025 | With an intuitive search engine for satellite data, the UZH Spin-off is putting Earth observation at the fingertips of the public – and has now received CHF 2.26 million to scale up its operations. askEarth was founded in 2022 as a UZH spin-off. Co-founder and CTO Simon Grüning was awarded a UZH Entrepreneur Fellowship in 2022. 

Entire news story
Entrepreneurship Fellow Profile Simon Grüning

Michal Shoshan

22.08.2025 | The UZH Spin-off announces a CHF 1 million funding from the UZH Life Sciences Fund. metaLead is developing a new class of metal-binding drugs aimed at overcoming the shortcomings of existing chelation therapies. Michal Soshan was awarded a UZH Entrepreneur Fellowship in 2023. 

Entire news story
Entrpreneur Fellow Profile Michal Shoshan